Sign in
8-K

Current Report

Damora Therapeutics, Inc. Filed Acc 0001193125-26-274093

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading dmra-20260428.htm…